A9579 HCPCS code: Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml
A9579 is the HCPCS Level II code for injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml. In 2024 Medicare paid an average of $1.15 per service for A9579 across 722,472 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 100 per day on outpatient hospital claims. Medicare volume fell 16% from 2022 to 2024 (858,733 to 722,472 services). In 2024, about 2,080 clinicians billed Medicare for A9579 for 42,189 beneficiaries; California, New York, Florida accounted for 47% of services.
Code details
| Field | Value |
|---|---|
| Section | A codes — Transportation, medical/surgical supplies and miscellaneous |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | I1E |
| Added | 2008-01-01 |
| Last action effective | 2008-01-01 |
Who bills A9579 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 2,080 |
| Medicare beneficiaries | 42,189 |
| States with claims | 48 |
| Share of services in top 3 states (California, New York, Florida) | 47% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for A9579, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 858,733 | 49,410 | $1.53 | $1.21 |
| 2023 | 784,880 | 47,578 | $1.52 | $1.20 |
| 2024 | 722,472 | 42,189 | $1.47 | $1.15 |
States with the most A9579 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| California | 132,791 | $1.17 |
| New York | 115,235 | $1.14 |
| Florida | 93,670 | $1.16 |
| Texas | 53,842 | $1.17 |
| Tennessee | 39,788 | $1.14 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 100 | Prescribing Information |
| practitioner claims | 100 | Prescribing Information |
What changed for A9579
- 2008-01-01: A9579 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code A9579?
A9579 is the HCPCS Level II code for injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml. Short descriptor: "Gad-base mr contrast nos,1ml".
How much does Medicare pay for A9579?
In 2024, the average Medicare payment was $1.15 per service (average allowed $1.47).
Does Medicare cover A9579?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of A9579 can be billed per day?
100 on outpatient hospital claims; 100 on practitioner claims (NCCI medically unlikely edits).
Related A95 codes
- A9500 — Technetium tc-99m sestamibi, diagnostic, per study dose
- A9501 — Technetium tc-99m teboroxime, diagnostic, per study dose
- A9502 — Technetium tc-99m tetrofosmin, diagnostic, per study dose
- A9503 — Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries
- A9504 — Technetium tc-99m apcitide, diagnostic, per study dose, up to 20 millicuries
- A9505 — Thallium tl-201 thallous chloride, diagnostic, per millicurie
- A9506 — Graphite crucible for preparation of technetium tc 99m-labeled carbon aerosol, one crucible
- A9507 — Indium in-111 capromab pendetide, diagnostic, per study dose, up to 10 millicuries
- A9508 — Iodine i-131 iobenguane sulfate, diagnostic, per 0.5 millicurie
- A9509 — Iodine i-123 sodium iodide, diagnostic, per millicurie
- A9510 — Technetium tc-99m disofenin, diagnostic, per study dose, up to 15 millicuries
- A9512 — Technetium tc-99m pertechnetate, diagnostic, per millicurie
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under A9579
- Watch A9579 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for A9579
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.